| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/28/1999 | US5958905 Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
| 09/28/1999 | US5958878 For treating male and non-pregnant female mammals |
| 09/28/1999 | US5958731 Cell junction PDZ protein |
| 09/28/1999 | US5958710 The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and |
| 09/28/1999 | US5958709 Processes for identifying compounds that bind to the human Y4 receptor |
| 09/23/1999 | WO1999047562A1 Nephrin gene and protein |
| 09/23/1999 | WO1999047554A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047490A1 Bicyclo[2.2.1]heptanes and related compounds |
| 09/23/1999 | WO1999047154A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | WO1999047144A1 Method and means for treating glomerulonephritis |
| 09/23/1999 | WO1999047134A1 Keto acid salts and amine derivatives, and their use for preparing medicines |
| 09/23/1999 | WO1999047132A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | WO1999032510A9 Kappa receptor opioid peptides |
| 09/23/1999 | CA2323439A1 Dipeptide caspase inhibitors and the use thereof |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | CA2321155A1 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 09/23/1999 | CA2317796A1 Method and means for treating glomerulonephritis |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0943328A2 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942911A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 09/22/1999 | EP0942910A1 1,4-diazabicyclo[2.2.2]oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 09/22/1999 | EP0942754A2 Conjugates useful in the treatment of prostate cancer |
| 09/22/1999 | EP0655063B1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 09/22/1999 | EP0609345B1 Biocompatible implant for the timing of ovulation in mares |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1228961A Application of alginic polysaccharide sulfate in preparation of medicine for treating renal failure |
| 09/21/1999 | US5955611 Cyclization of diamidepyrazole to form pyrimidone of pyrazole |
| 09/21/1999 | US5955492 Carboxylic acid indole inhibitors of chemokines |
| 09/21/1999 | US5955440 Macrolide LHRH antagonists |
| 09/21/1999 | US5955365 Introducing polynucleotides into cells |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | CA2135751C 4-mercaptoacetylamino-¬2| benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
| 09/21/1999 | CA1340762C Recombinant birth control vaccine |
| 09/16/1999 | WO1999046375A2 Human nucleic acid sequences from prostate tissue |
| 09/16/1999 | WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999045918A1 Methods and compositions for delivery of taxanes |
| 09/16/1999 | WO1999045779A1 Novel compositions of eprosartan |
| 09/16/1999 | WO1999028304A9 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 09/16/1999 | WO1999015657A3 53bp2 complexes |
| 09/16/1999 | DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents |
| 09/16/1999 | DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents |
| 09/16/1999 | CA2323089A1 Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | CA2288240A1 Methods and compositions for delivery of taxanes |
| 09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 09/15/1999 | EP0941247A2 Peptide compounds useful for modulating fgf receptor activity |
| 09/15/1999 | EP0941111A1 Hepatocyte growth factor antagonists |
| 09/15/1999 | EP0941108A1 Wound healing and treatment of fibrosis |
| 09/15/1999 | EP0804239B1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | EP0656001B1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228707A Titanium slow-release composition |
| 09/15/1999 | CN1228700A Tablet with controlled release of alfuzosine chlorydrate |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228321A Drug for curing stone of urinary system |
| 09/14/1999 | US5952513 Benzo b! thiophene compounds |
| 09/14/1999 | US5952364 Methods for inhibiting smooth muscle cell proliferation |
| 09/14/1999 | US5952362 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxyphenyl, and aminophenyl alkylsulfonamides and ureas and their use |
| 09/14/1999 | US5952322 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
| 09/10/1999 | WO1999045099A1 New agent |
| 09/10/1999 | WO1999045009A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 09/10/1999 | WO1999044998A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists |
| 09/10/1999 | WO1999044643A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 09/10/1999 | WO1999044628A1 Conjugates useful in the treatment of prostate cancer |
| 09/10/1999 | WO1999044613A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v1a and v2 receptors |
| 09/10/1999 | WO1999044599A1 Therapeutic treatment for renal dysfunction |
| 09/10/1999 | WO1999023078A3 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists |
| 09/10/1999 | CA2323172A1 Therapeutic treatment for renal dysfunction |
| 09/10/1999 | CA2322541A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists |
| 09/10/1999 | CA2321171A1 Conjugates useful in the treatment of prostate cancer |
| 09/09/1999 | DE19809144A1 Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten New asymmetrically substituted carboxylic acid derivatives, their preparation and use as a mixed ET¶LAMBDA¶ / ET¶B¶ receptor antagonists |
| 09/08/1999 | EP0940391A2 Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 09/08/1999 | EP0939751A1 Macrophage lipid chemoattractant |
| 09/08/1999 | EP0939633A1 Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1227751A Chinese medicine preparation for curing hyperplasia of prostate and preparing process thereof |
| 09/07/1999 | US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate |
| 09/07/1999 | US5948804 Anaesthetic premedication |
| 09/07/1999 | US5948802 Stroke, anticonvulsants, antiepilepic agents, antiasthma agents, migraines, nervous system disorders, sexual disorders, incotinence |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | CA2168563C Benzopyrans and pharmaceutical compositions containing them |
| 09/07/1999 | CA2014008C Benzimidazoles, medicaments containing these compounds and processes for their preparation |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043663A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | WO1999043657A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 09/02/1999 | WO1999043310A2 20-hete antagonists and agonists |
| 09/02/1999 | WO1999043271A1 Injectable implants for tissue augmentation and restoration |
| 09/02/1999 | CA2321642A1 N-¬(substituted five-membered di- or triaza diunsaturated ring)carbonyl|guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | CA2319558A1 Injectable implants for tissue augmentation and restoration |
| 09/01/1999 | EP0939085A1 A process for the purification of a motility-promoting protein from buffalo serum |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |